NIH-funded research R01 grant

How glutamine affects the development of immune cells called dendritic cells

Official title: Role of glutamine metabolism in Dendritic Cell Development

Funded at University of Pennsylvania · NIH-10914888 · Data updated 2026-11-12

This study is looking at how glutamine, a type of nutrient, affects the growth of important immune cells called dendritic cells, which help our body fight off infections and cancer, to find new ways to improve treatments for autoimmune diseases and cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$312,000
NIH project number5R01DK138827-02
Project IDNIH-10914888 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with autoimmune diseases or cancers who may have altered immune responses.

Less likely to help

Patients with stable, non-immune related conditions may not receive any benefit from this research.

What this research studies

This research investigates the role of glutamine metabolism in the development of dendritic cells, which are crucial for the immune system's ability to recognize and respond to pathogens and cancer. The study focuses on how the availability of glutamine in different tissue environments influences the differentiation of dendritic cells from their precursors. By understanding these metabolic processes, the research aims to uncover new insights into how immune responses can be modulated, potentially leading to improved treatments for autoimmune diseases and cancers.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing immune responses against infections and tumors.

How similar studies have gone: Other research has shown promising results in understanding immune cell differentiation through metabolic pathways, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Haldar, Malay — University of Pennsylvania
  • Study coordinator: Haldar, Malay

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.